 | • レポートコード：D005-00489 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ホルモン避妊薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ホルモン避妊薬の種類別市場規模（経口避妊薬、注射避妊薬、緊急避妊薬、膣リング、経皮パッチ）、用途別市場規模（病院、家庭、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Ansell Limited、Pfizer、Johnson and Johnson、Bayer AG、Mylan N.V.、Church and Dwight Co、The Female Health Company、Merck and Co、Mayer Laboratories、Teva Pharmaceutical Industries、Organon International、Afaxys ・地域別グローバル市場分析 2015年-2020年 ・ホルモン避妊薬の北米市場（アメリカ、カナダ、メキシコ） ・ホルモン避妊薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ホルモン避妊薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ホルモン避妊薬の南米市場（ブラジル、アルゼンチン） ・ホルモン避妊薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口避妊薬、注射避妊薬、緊急避妊薬、膣リング、経皮パッチ ・用途別分析：病院、家庭、クリニック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Hormonal Contraceptive market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.7% in the forecast period of 2020 to 2025 and will expected to reach USD 20020 million by 2025, from USD 17990 million in 2019.
The Hormonal Contraceptive market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Hormonal Contraceptive market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Hormonal Contraceptive market has been segmented into:
Oral Contraceptive Pills
Injectable Birth Control
Emergency Contraceptive Pills
Vaginal Rings
Transdermal Patches
By Application, Hormonal Contraceptive has been segmented into:
Hospitals
Household
Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hormonal Contraceptive market presented in the report. This section sheds light on the sales growth of different regional and country-level Hormonal Contraceptive markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hormonal Contraceptive market.
The report offers in-depth assessment of the growth and other aspects of the Hormonal Contraceptive market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Hormonal Contraceptive Market Share Analysis
Hormonal Contraceptive competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hormonal Contraceptive sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hormonal Contraceptive sales, revenue and market share for each player covered in this report.
The major players covered in Hormonal Contraceptive are:
Ansell Limited
Pfizer
Johnson and Johnson
Bayer AG
Mylan N.V.
Church and Dwight Co
The Female Health Company
Merck and Co
Mayer Laboratories
Teva Pharmaceutical Industries
Organon International
Afaxys
Table of Contents
1 Hormonal Contraceptive Market Overview
1.1 Product Overview and Scope of Hormonal Contraceptive
1.2 Classification of Hormonal Contraceptive by Type
1.2.1 Global Hormonal Contraceptive Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Hormonal Contraceptive Revenue Market Share by Type in 2019
1.2.3 Oral Contraceptive Pills
1.2.4 Injectable Birth Control
1.2.5 Emergency Contraceptive Pills
1.2.6 Vaginal Rings
1.2.7 Transdermal Patches
1.3 Global Hormonal Contraceptive Market by Application
1.3.1 Overview: Global Hormonal Contraceptive Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Household
1.3.4 Clinics
1.4 Global Hormonal Contraceptive Market by Regions
1.4.1 Global Hormonal Contraceptive Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Hormonal Contraceptive (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Hormonal Contraceptive Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Hormonal Contraceptive Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hormonal Contraceptive Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Hormonal Contraceptive Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hormonal Contraceptive Status and Prospect (2015-2025)
2 Company Profiles
2.1 Ansell Limited
2.1.1 Ansell Limited Details
2.1.2 Ansell Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Ansell Limited SWOT Analysis
2.1.4 Ansell Limited Product and Services
2.1.5 Ansell Limited Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson and Johnson SWOT Analysis
2.3.4 Johnson and Johnson Product and Services
2.3.5 Johnson and Johnson Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer AG SWOT Analysis
2.4.4 Bayer AG Product and Services
2.4.5 Bayer AG Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mylan N.V.
2.5.1 Mylan N.V. Details
2.5.2 Mylan N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mylan N.V. SWOT Analysis
2.5.4 Mylan N.V. Product and Services
2.5.5 Mylan N.V. Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
2.6 Church and Dwight Co
2.6.1 Church and Dwight Co Details
2.6.2 Church and Dwight Co Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Church and Dwight Co SWOT Analysis
2.6.4 Church and Dwight Co Product and Services
2.6.5 Church and Dwight Co Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
2.7 The Female Health Company
2.7.1 The Female Health Company Details
2.7.2 The Female Health Company Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 The Female Health Company SWOT Analysis
2.7.4 The Female Health Company Product and Services
2.7.5 The Female Health Company Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck and Co
2.8.1 Merck and Co Details
2.8.2 Merck and Co Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck and Co SWOT Analysis
2.8.4 Merck and Co Product and Services
2.8.5 Merck and Co Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mayer Laboratories
2.9.1 Mayer Laboratories Details
2.9.2 Mayer Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mayer Laboratories SWOT Analysis
2.9.4 Mayer Laboratories Product and Services
2.9.5 Mayer Laboratories Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Teva Pharmaceutical Industries SWOT Analysis
2.10.4 Teva Pharmaceutical Industries Product and Services
2.10.5 Teva Pharmaceutical Industries Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
2.11 Organon International
2.11.1 Organon International Details
2.11.2 Organon International Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Organon International SWOT Analysis
2.11.4 Organon International Product and Services
2.11.5 Organon International Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
2.12 Afaxys
2.12.1 Afaxys Details
2.12.2 Afaxys Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Afaxys SWOT Analysis
2.12.4 Afaxys Product and Services
2.12.5 Afaxys Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Hormonal Contraceptive Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Hormonal Contraceptive Players Market Share
3.2.2 Top 10 Hormonal Contraceptive Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Hormonal Contraceptive Revenue and Market Share by Regions
4.2 North America Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
4.3 Europe Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
4.5 South America Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
5 North America Hormonal Contraceptive Revenue by Countries
5.1 North America Hormonal Contraceptive Revenue by Countries (2015-2020)
5.2 USA Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
5.3 Canada Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
5.4 Mexico Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
6 Europe Hormonal Contraceptive Revenue by Countries
6.1 Europe Hormonal Contraceptive Revenue by Countries (2015-2020)
6.2 Germany Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
6.3 UK Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
6.4 France Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
6.5 Russia Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
6.6 Italy Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Hormonal Contraceptive Revenue by Countries
7.1 Asia-Pacific Hormonal Contraceptive Revenue by Countries (2015-2020)
7.2 China Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
7.3 Japan Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
7.4 Korea Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
7.5 India Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
8 South America Hormonal Contraceptive Revenue by Countries
8.1 South America Hormonal Contraceptive Revenue by Countries (2015-2020)
8.2 Brazil Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
8.3 Argentina Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Hormonal Contraceptive by Countries
9.1 Middle East & Africa Hormonal Contraceptive Revenue by Countries (2015-2020)
9.2 Saudi Arabia Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
9.3 UAE Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
9.4 Egypt Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
9.5 South Africa Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Hormonal Contraceptive Revenue and Market Share by Type (2015-2020)
10.2 Global Hormonal Contraceptive Market Forecast by Type (2019-2024)
10.3 Oral Contraceptive Pills Revenue Growth Rate (2015-2025)
10.4 Injectable Birth Control Revenue Growth Rate (2015-2025)
10.5 Emergency Contraceptive Pills Revenue Growth Rate (2015-2025)
10.6 Vaginal Rings Revenue Growth Rate (2015-2025)
10.7 Transdermal Patches Revenue Growth Rate (2015-2025)
11 Global Hormonal Contraceptive Market Segment by Application
11.1 Global Hormonal Contraceptive Revenue Market Share by Application (2015-2020)
11.2 Hormonal Contraceptive Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Household Revenue Growth (2015-2020)
11.5 Clinics Revenue Growth (2015-2020)
12 Global Hormonal Contraceptive Market Size Forecast (2021-2025)
12.1 Global Hormonal Contraceptive Market Size Forecast (2021-2025)
12.2 Global Hormonal Contraceptive Market Forecast by Regions (2021-2025)
12.3 North America Hormonal Contraceptive Revenue Market Forecast (2021-2025)
12.4 Europe Hormonal Contraceptive Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Hormonal Contraceptive Revenue Market Forecast (2021-2025)
12.6 South America Hormonal Contraceptive Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Hormonal Contraceptive Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Hormonal Contraceptive Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hormonal Contraceptive by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hormonal Contraceptive Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Hormonal Contraceptive Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Ansell Limited Corporate Information, Location and Competitors
Table 6. Ansell Limited Hormonal Contraceptive Major Business
Table 7. Ansell Limited Hormonal Contraceptive Total Revenue (USD Million) (2017-2018)
Table 8. Ansell Limited SWOT Analysis
Table 9. Ansell Limited Hormonal Contraceptive Product and Solutions
Table 10. Ansell Limited Hormonal Contraceptive Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pfizer Corporate Information, Location and Competitors
Table 12. Pfizer Hormonal Contraceptive Major Business
Table 13. Pfizer Hormonal Contraceptive Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer SWOT Analysis
Table 15. Pfizer Hormonal Contraceptive Product and Solutions
Table 16. Pfizer Hormonal Contraceptive Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Johnson and Johnson Corporate Information, Location and Competitors
Table 18. Johnson and Johnson Hormonal Contraceptive Major Business
Table 19. Johnson and Johnson Hormonal Contraceptive Total Revenue (USD Million) (2017-2018)
Table 20. Johnson and Johnson SWOT Analysis
Table 21. Johnson and Johnson Hormonal Contraceptive Product and Solutions
Table 22. Johnson and Johnson Hormonal Contraceptive Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer AG Corporate Information, Location and Competitors
Table 24. Bayer AG Hormonal Contraceptive Major Business
Table 25. Bayer AG Hormonal Contraceptive Total Revenue (USD Million) (2017-2018)
Table 26. Bayer AG SWOT Analysis
Table 27. Bayer AG Hormonal Contraceptive Product and Solutions
Table 28. Bayer AG Hormonal Contraceptive Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Mylan N.V. Corporate Information, Location and Competitors
Table 30. Mylan N.V. Hormonal Contraceptive Major Business
Table 31. Mylan N.V. Hormonal Contraceptive Total Revenue (USD Million) (2017-2018)
Table 32. Mylan N.V. SWOT Analysis
Table 33. Mylan N.V. Hormonal Contraceptive Product and Solutions
Table 34. Mylan N.V. Hormonal Contraceptive Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Church and Dwight Co Corporate Information, Location and Competitors
Table 36. Church and Dwight Co Hormonal Contraceptive Major Business
Table 37. Church and Dwight Co Hormonal Contraceptive Total Revenue (USD Million) (2017-2018)
Table 38. Church and Dwight Co SWOT Analysis
Table 39. Church and Dwight Co Hormonal Contraceptive Product and Solutions
Table 40. Church and Dwight Co Hormonal Contraceptive Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. The Female Health Company Corporate Information, Location and Competitors
Table 42. The Female Health Company Hormonal Contraceptive Major Business
Table 43. The Female Health Company Hormonal Contraceptive Total Revenue (USD Million) (2017-2018)
Table 44. The Female Health Company SWOT Analysis
Table 45. The Female Health Company Hormonal Contraceptive Product and Solutions
Table 46. The Female Health Company Hormonal Contraceptive Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Merck and Co Corporate Information, Location and Competitors
Table 48. Merck and Co Hormonal Contraceptive Major Business
Table 49. Merck and Co Hormonal Contraceptive Total Revenue (USD Million) (2017-2018)
Table 50. Merck and Co SWOT Analysis
Table 51. Merck and Co Hormonal Contraceptive Product and Solutions
Table 52. Merck and Co Hormonal Contraceptive Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Mayer Laboratories Corporate Information, Location and Competitors
Table 54. Mayer Laboratories Hormonal Contraceptive Major Business
Table 55. Mayer Laboratories Hormonal Contraceptive Total Revenue (USD Million) (2017-2018)
Table 56. Mayer Laboratories SWOT Analysis
Table 57. Mayer Laboratories Hormonal Contraceptive Product and Solutions
Table 58. Mayer Laboratories Hormonal Contraceptive Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Teva Pharmaceutical Industries Corporate Information, Location and Competitors
Table 60. Teva Pharmaceutical Industries Hormonal Contraceptive Major Business
Table 61. Teva Pharmaceutical Industries Hormonal Contraceptive Total Revenue (USD Million) (2017-2018)
Table 62. Teva Pharmaceutical Industries SWOT Analysis
Table 63. Teva Pharmaceutical Industries Hormonal Contraceptive Product and Solutions
Table 64. Teva Pharmaceutical Industries Hormonal Contraceptive Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Organon International Corporate Information, Location and Competitors
Table 66. Organon International Hormonal Contraceptive Major Business
Table 67. Organon International Hormonal Contraceptive Total Revenue (USD Million) (2017-2018)
Table 68. Organon International SWOT Analysis
Table 69. Organon International Hormonal Contraceptive Product and Solutions
Table 70. Organon International Hormonal Contraceptive Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Afaxys Corporate Information, Location and Competitors
Table 72. Afaxys Hormonal Contraceptive Major Business
Table 73. Afaxys Hormonal Contraceptive Total Revenue (USD Million) (2017-2018)
Table 74. Afaxys SWOT Analysis
Table 75. Afaxys Hormonal Contraceptive Product and Solutions
Table 76. Afaxys Hormonal Contraceptive Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Hormonal Contraceptive Revenue (Million USD) by Players (2015-2020)
Table 78. Global Hormonal Contraceptive Revenue Share by Players (2015-2020)
Table 79. Global Hormonal Contraceptive Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Hormonal Contraceptive Revenue Market Share by Regions (2015-2020)
Table 81. North America Hormonal Contraceptive Revenue by Countries (2015-2020)
Table 82. North America Hormonal Contraceptive Revenue Market Share by Countries (2015-2020)
Table 83. Europe Hormonal Contraceptive Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Hormonal Contraceptive Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Hormonal Contraceptive Revenue by Countries (2015-2020)
Table 86. South America Hormonal Contraceptive Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Hormonal Contraceptive Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Hormonal Contraceptive Revenue Market Share by Countries (2015-2020)
Table 89. Global Hormonal Contraceptive Revenue (Million USD) by Type (2015-2020)
Table 90. Global Hormonal Contraceptive Revenue Share by Type (2015-2020)
Table 91. Global Hormonal Contraceptive Revenue Forecast by Type (2021-2025)
Table 92. Global Hormonal Contraceptive Revenue by Application (2015-2020)
Table 93. Global Hormonal Contraceptive Revenue Share by Application (2015-2020)
Table 94. Global Hormonal Contraceptive Revenue Forecast by Application (2021-2025)
Table 95. Global Hormonal Contraceptive Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Hormonal Contraceptive Picture
Figure 2. Global Hormonal Contraceptive Revenue Market Share by Type in 2019
Figure 3. Oral Contraceptive Pills Picture
Figure 4. Injectable Birth Control Picture
Figure 5. Emergency Contraceptive Pills Picture
Figure 6. Vaginal Rings Picture
Figure 7. Transdermal Patches Picture
Figure 8. Hormonal Contraceptive Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Household Picture
Figure 11. Clinics Picture
Figure 12. Global Hormonal Contraceptive Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Hormonal Contraceptive Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Hormonal Contraceptive Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Hormonal Contraceptive Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Hormonal Contraceptive Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Hormonal Contraceptive Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Hormonal Contraceptive Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Hormonal Contraceptive Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Hormonal Contraceptive Revenue Market Share in 2019
Figure 21. Global Top 10 Players Hormonal Contraceptive Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Hormonal Contraceptive Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Hormonal Contraceptive Revenue Market Share by Regions (2015-2020)
Figure 25. Global Hormonal Contraceptive Revenue Market Share by Regions in 2018
Figure 26. North America Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 27. Europe Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 29. South America Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 31. North America Hormonal Contraceptive Revenue Market Share by Countries (2015-2020)
Figure 32. North America Hormonal Contraceptive Revenue Market Share by Countries in 2019
Figure 33. USA Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 34. Canada Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 36. Europe Hormonal Contraceptive Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Hormonal Contraceptive Revenue Market Share by Countries in 2019
Figure 38. Germany Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 39. UK Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 40. France Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 41. Russia Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 42. Italy Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Hormonal Contraceptive Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Hormonal Contraceptive Revenue Market Share by Countries in 2019
Figure 45. China Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 46. Japan Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 47. Korea Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 48. India Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 50. South America Hormonal Contraceptive Revenue Market Share by Countries (2015-2020)
Figure 51. South America Hormonal Contraceptive Revenue Market Share by Countries in 2019
Figure 52. Brazil Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Hormonal Contraceptive Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Hormonal Contraceptive Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 57. UAE Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
Figure 60. Global Hormonal Contraceptive Revenue Share by Type (2015-2020)
Figure 61. Global Hormonal Contraceptive Revenue Share by Type in 2019
Figure 62. Global Hormonal Contraceptive Market Share Forecast by Type (2021-2025)
Figure 63. Global Oral Contraceptive Pills Revenue Growth Rate (2015-2020)
Figure 64. Global Injectable Birth Control Revenue Growth Rate (2015-2020)
Figure 65. Global Emergency Contraceptive Pills Revenue Growth Rate (2015-2020)
Figure 66. Global Vaginal Rings Revenue Growth Rate (2015-2020)
Figure 67. Global Transdermal Patches Revenue Growth Rate (2015-2020)
Figure 68. Global Hormonal Contraceptive Revenue Share by Application (2015-2020)
Figure 69. Global Hormonal Contraceptive Revenue Share by Application in 2019
Figure 70. Global Hormonal Contraceptive Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Household Revenue Growth Rate (2015-2020)
Figure 73. Global Clinics Revenue Growth Rate (2015-2020)
Figure 74. Global Hormonal Contraceptive Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Hormonal Contraceptive Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Hormonal Contraceptive Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Hormonal Contraceptive Revenue Market Forecast (2021-2025)
Figure 78. Europe Hormonal Contraceptive Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Hormonal Contraceptive Revenue Market Forecast (2021-2025)
Figure 80. South America Hormonal Contraceptive Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Hormonal Contraceptive Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
配合経口避妊薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Combined Hormonal Contraceptives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 20710 million by 2025, from USD 18300 million in 2019. The Combi…- 避妊薬＆器具の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Contraceptives Drugs and Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.5% in the forecast period of 2020 to 2025 and will expected to reach USD 24150 million by 2025, from USD 18110 million in 2019. The Contr…
- 多嚢胞性卵巣症候群の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Polycystic Ovary Syndrome market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Polycystic Ovary Sy…
- 女性用避妊薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Female Contraceptives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Female Contraceptives m…
- 泌尿生殖器薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Genitourinary Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genitourinary Drugs marke…